| Application no. and date | 14820814.3 (espacenet) (Federated) (European Patent Register), 20141215 | | Patent/reg. no. and date | DK/EP 3082773, 20171004 | | Publication date | 20161026 | | Priority no. and date | EP 13197606, 20131217 | | EP pub. no. and date |
EP 3082773 20161026 | | Effective date | | | Applicant/owner | ObsEva S.A., 12, Chemin des Aulx
1228 Plan-les-Ouates/Geneve, CH | | Applicant ref. no. | P23181DKEP | | Inventor | CHOLLET, Andre, c/o OBSEVA S.A.
Chemin des Aulx 12
1228 Plan-Les-Ouates, CH,
POHL, Olivier, c/o OBSEVA S.A.
Chemin des Aulx 12
1228 Plan-Les-Ouates, CH | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 31/40 (2006.01) , A61K 31/401 (2006.01) , A61K 45/06 (2006.01) , A61K 47/40 (2006.01) , A61K 9/00 (2006.01) , A61K 9/20 (2006.01) | | Title | Orale formuleringer af pyrrolidinderivater | | Int. application no. | EP2014077767 | | Int. publication no. | WO2015091365 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
